Statin Use and the Risk of Graves’ Orbitopathy: A Nationwide Population-Based Cohort Study
Thyroid® · 2025
DOI: 10.1089/thy.2024.0536 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Thyroid®, 2025. Verfasst von Yu-Tsung Chou und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Management Center, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan. Hauptthemen laut MEDLINE: Hydroxymethylglutaryl-CoA Reductase Inhibitors, Graves Ophthalmopathy. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: National Health Research Institute.
Abstract (Originalsprache)
Background
Statin use is reported to reduce the risk of Graves’ orbitopathy (GO) in Western populations. However, study regarding the protective effect of statins against GO in Asians with Graves’ disease (GD) is scarce. This study aims to investigate the efficacy of statins in preventing GO in Asian GD patients. Materials and Methods: This nationwide, population-based retrospective cohort study used data from beneficiaries aged >40 years diagnosed with GD from the National Health Insurance Research Database (NHIRD) from 2010 to 2020. The International Classification of Diseases codes, Anatomical Therapeutic Chemical codes, and the surgery/procedure codes derived from the NHIRD were used to obtain the information on GD, GO, and statin use. Propensity score (PS) analysis with matching and inverse probability of treatment weighting analysis (IPTW) was conducted to minimize confounding. The Kaplan–Meier survival analysis and multivariable Cox regression analysis were used to compare the risk of GO among statin users and nonusers.
Results
The final analysis included 102,858 patients; 7,073 were statin users (62.9 ± 10.6 years, 29.7% male), and 95,785 were nonusers (53.6 ± 10.4 years, 25.7% male). The crude incidence rate of GO among statin users and nonusers was 5.00‰ versus 6.75‰ and 4.91‰ versus 5.15‰ for the overall population and population after PS matching method, respectively. The Cox regression analysis showed that statin users had a significantly lower risk of GO (adjusted hazard ratio [HR] after PS matching 0.79, 95% confidence interval [CI]: 0.63–0.99, p = 0.037; adjusted HR after IPTW method: 0.64, CI: 0.51–0.79, p < 0.001). The risk of GO was not different among users of different kinds of statins (i.e., atorvastatin, rosuvastatin, pitavastatin, and other statins) or among different intensities of statins (low-to-moderate intensity vs. high intensity).
Conclusions
The use of statins in Asian GD patients was associated with a reduced risk of GO. In addition, the risk of developing GO among users of commonly prescribed statins or users of different intensities of statins was not significantly different.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Health Management Center, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
- Department of Family Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
- Department of Ophthalmology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
- Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
- Department of Public Health, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
- Department of Healthcare Administration, College of Medical and Health Science, Asia University, Taichung, Taiwan.
ORCID-Profile: Yi-Ching Yang
Förderung
- National Health Research Institute
Zitieren
APA
Chou, Y. T., Lai, C. C., Li, C. Y., Shen, W. C., Huang, Y. T., Wu, Y. L., Lin, Y. H., Yang, D. C., & Yang, Y. C. (2025). Statin Use and the Risk of Graves’ Orbitopathy: A Nationwide Population-Based Cohort Study. Thyroid®. https://doi.org/10.1089/thy.2024.0536
Vancouver
Chou YT, Lai CC, Li CY, Shen WC, Huang YT, Wu YL, et al. Statin Use and the Risk of Graves’ Orbitopathy: A Nationwide Population-Based Cohort Study. Thyroid®. 2025. doi:10.1089/thy.2024.0536
BibTeX
@article{Chou2025,
author = {Chou, Yu-Tsung and Lai, Chun-Chieh and Li, Chung-Yi and Shen, Wei-Chen and Huang, Yu-Tung and Wu, Yi-Lin and Lin, Yi-Hsuan and Yang, Deng-Chi and Yang, Yi-Ching},
title = {Statin Use and the Risk of Graves’ Orbitopathy: A Nationwide Population-Based Cohort Study},
journal = {Thyroid®},
year = {2025},
doi = {10.1089/thy.2024.0536}
}
EUVIMED